| Joshua Herring, DO | |
|
Building 99 Unit 5024, Misawa Air Base, Apo, AP 96319-0068 | |
| (315) 226-6133 | |
| Not Available |
| Full Name | Joshua Herring |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | Building 99 Unit 5024, Apo, Armed Forces Pacific |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295295640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2020036789 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Herring, DO Building 99 Unit 5024, Misawa Air Base, Apo, AP 96319-0068 Ph: (315) 226-6133 | Joshua Herring, DO Building 99 Unit 5024, Misawa Air Base, Apo, AP 96319-0068 Ph: (315) 226-6133 |
News Archive
Non-alcoholic fatty liver disease (NAFLD) is a common affliction, affecting almost 30 percent of Americans, with a significant number suffering from its most severe form, called non-alcoholic steatohepatitis or NASH, which can lead to cirrhosis and liver cancer. In recent years, NASH has become the leading cause of liver transplantation.
Meridian Health, a leading health care system in New Jersey, joined a national movement called "The Baton Pass™" to help raise funds for innovative cancer research and spread a message of hope.
The brains of older people are not slower but rather wiser than young brains, which allows older adults to achieve an equivalent level of performance, according research undertaken at the University Geriatrics Institute of Montreal by Dr. Oury Monchi and Dr. Ruben Martins of the Univeristy of Montreal.
Researchers have studied existing evidence to suggest that people who have had a stroke or a heart attack might benefit from taking blood pressure medications, even if they do not have high blood. They noted that for every 1,000 people taking the drugs in clinical trials, on average 15 fewer died from heart disease than when the patients got dummy treatment. The study however could not explain the cause for this benefit. The study, which was funded by Tulane University and the National Institutes of Health, was published in the March 2 issue of the Journal of the American Medical Association.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009.
› Verified 8 days ago
Danielle Dawn Acacio, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Kunsan Ab, Apo, AP 96264 Phone: 315-782-2273 | |
Shelley Raska, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 18th Medical Group, Unit 5142, Apo, AP 96368 Phone: 518-630-4229 | |
Andrew Thomas Bushong, Family Medicine Medicare: Medicare Enrolled Practice Location: Unit 2022 Box 8th, Apo, AP 96264 Phone: 315-784-5227 | |
Akira Miyanari, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 18th Medical Group, Unit 5142, Apo, AP 96368 Phone: 098-960-4817 | |
Anil Rajan, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 18 Th Medical Group, Unit 5142, Apo, AP 96368 Phone: 630-960-4305 | |
Dr. Arthur New Lawrance Jr., DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Unit 5142 Box 18th, Apo, AP 96368 Phone: 315-630-0151 | |
Ryan Mark, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 18th Medical Group, Unit 5142, Apo, AP 96368 Phone: 681-342-3600 |